Fig. 1 | Nature Communications

Fig. 1

From: Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery

Fig. 1The alternative text for this image may have been generated using AI.

Drug stability in ISFI formulation by DSC analysis. DSC thermograms: a PLGA (neat; 50:50 LA:GA, MW 27 kDa), b 1:2 PLGA/NMP Placebo ISFI, c MK-2048 (neat), d 0.9:1:2 MK-2048/PLGA/NMP ISFI, e DTG (neat), f 0.3:1:2 DTG/PLGA/NMP; the PLGA peak at ~40–50 °C is not visible due to scale relative to the strong DTG peak. Endodermic peaks with the respective glass transition and melting temperatures are indicated in each panel

Back to article page